Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: A report from an international DLBCL rituximab-CHOP consortium program study

Carlo Visco, Alexander Tzankov, Zijun Y. Xu-Monette, Roberto N. Miranda, Yu Chuan Tai, Yan Li, Wei Min Liu, Emanuele S G d'Amore, Yong Li, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Huan You Wang, Cherie H. Dunphy, Eric D. His, X. Frank Zhao, William W L ChoiXiaoying Zhao, J. Han van Krieken, Qin Huang, Weiyun Ai, Stacey O'Neill, Maurilio Ponzoni, Andres J M Ferreri, Brad S. Kahl, Jane N. Winter, Ronald S. Go, Stephan Dirnhofer, Miguel A. Piris, Michael B. Møller, Lin Wu, L. Jeffrey Medeiros, Ken H. Young

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: A report from an international DLBCL rituximab-CHOP consortium program study'. Together they form a unique fingerprint.

Medicine & Life Sciences